<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">40892409</PMID><DateCompleted><Year>2025</Year><Month>09</Month><Day>02</Day></DateCompleted><DateRevised><Year>2025</Year><Month>09</Month><Day>05</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2574-3805</ISSN><JournalIssue CitedMedium="Internet"><Volume>8</Volume><Issue>9</Issue><PubDate><Year>2025</Year><Month>Sep</Month><Day>02</Day></PubDate></JournalIssue><Title>JAMA network open</Title><ISOAbbreviation>JAMA Netw Open</ISOAbbreviation></Journal><ArticleTitle>Behavioral Economic Framing for Enrollment and Retention of Patients in Remote Blood Pressure Monitoring: A Randomized Clinical Trial.</ArticleTitle><Pagination><StartPage>e2529825</StartPage><MedlinePgn>e2529825</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e2529825</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1001/jamanetworkopen.2025.29825</ELocationID><Abstract><AbstractText Label="IMPORTANCE" NlmCategory="UNASSIGNED">Remote blood pressure (BP) monitoring for hypertension has been limited by low participation and engagement.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="UNASSIGNED">To evaluate if an opt-out behavioral economic approach to remote BP monitoring improves enrollment and BP outcomes compared with an opt-in approach.</AbstractText><AbstractText Label="DESIGN, SETTING, AND PARTICIPANTS" NlmCategory="UNASSIGNED">This pragmatic, 3-arm randomized clinical trial included patients aged 18 to 75 years with hypertension who were followed up by an academic family medicine practice in Philadelphia. Eligible patients used text messaging, had at least 2 elevated BP measurements during the prior 24 months, and were prescribed hypertension medication. Patients were randomized beginning February 25, 2021, and the last patient completed the program March 22, 2022. Data were analyzed from December 2023 to January 2024.</AbstractText><AbstractText Label="INTERVENTIONS" NlmCategory="UNASSIGNED">Prior to consent, patients were randomized 2:2:1 to opt-in or opt-out recruitment for remote monitoring of BP or to usual-care control. The opt-in group received outreach to consent and enroll in remote monitoring, and those who consented received a home BP monitor; the opt-out group received a home BP monitor and similar recruitment and follow-up. For 6 months, participants in the opt-in and opt-out groups received weekly text messages requesting BP readings and received support from a social partner or clinician as needed.</AbstractText><AbstractText Label="MAIN OUTCOMES AND MEASURES" NlmCategory="UNASSIGNED">The primary outcome was the proportion of all participants in the intervention arms consenting to enroll in remote BP monitoring. Secondary outcomes for the intervention groups included number of BP measurements submitted and proportion of patients actively engaged. Secondary outcomes for all participants were BP measurements and the proportion with controlled BP.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Among 424 randomized patients (171 opt-in, 168 opt-out, and 85 control), the mean (SD) age was 52.1 (11.5) years, and 264 (62.3%) were female. A total of 58 patients (33.9%) in the opt-in and 63 (37.5%) in the opt-out arm consented to enroll in monitoring, yielding no significant difference in enrollment rate (3.6 percentage points [pp]; 90% CI, -5.0 to 12.1 pp; P&#x2009;=&#x2009;.49). There was no difference in the mean number of BP measurements submitted (unadjusted difference, -0.03 [95% CI, -0.09 to 0.03] measurements; P&#x2009;=&#x2009;.30) or proportion of actively engaged patients (absolute difference, -0.7 pp [90% CI, -15.6 to 14.3 pp]; P&#x2009;=&#x2009;.94) between intervention arms. Using BP measurements from clinic visits, 55 patients (32.2%) in the opt-in arm and 64 (38.1%) in the opt-out arm had controlled BP, compared with 18 (21.2%) in the control arm (opt-in difference vs control, 11.7 pp [95% CI, -0.2 to 23.5 pp]; P&#x2009;=&#x2009;.05; opt-out difference vs control, 18.0 pp [95% CI, 6.1-30.0 pp]; P&#x2009;=&#x2009;.003).</AbstractText><AbstractText Label="CONCLUSIONS AND RELEVANCE" NlmCategory="UNASSIGNED">In this randomized clinical trial, the behavioral economic approach of opt-out framing vs opt-in framing did not improve enrollment and retention of patients in a remote BP monitoring program. The findings suggest additional approaches are needed to boost participation.</AbstractText><AbstractText Label="TRIAL REGISTRATION" NlmCategory="UNASSIGNED">ClinicalTrials.gov Identifier: NCT04714398.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mehta</LastName><ForeName>Shivan J</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Health Care Transformation and Innovation, University of Pennsylvania, Philadelphia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Health Incentives and Behavioral Economics, Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Teel</LastName><ForeName>Joseph</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Family Medicine and Community Health, Perelman School of Medicine, University of Pennsylvania, Philadelphia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Okorie</LastName><ForeName>Evelyn</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Health Care Transformation and Innovation, University of Pennsylvania, Philadelphia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reitz</LastName><ForeName>Catherine</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Health Care Transformation and Innovation, University of Pennsylvania, Philadelphia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Purcell</LastName><ForeName>Alison</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Family Medicine and Community Health, Perelman School of Medicine, University of Pennsylvania, Philadelphia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Snider</LastName><ForeName>Christopher K</ForeName><Initials>CK</Initials><AffiliationInfo><Affiliation>Center for Health Care Transformation and Innovation, University of Pennsylvania, Philadelphia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Clark</LastName><ForeName>Kayla</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Center for Health Incentives and Behavioral Economics, Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kersting</LastName><ForeName>Rebecca C</ForeName><Initials>RC</Initials><AffiliationInfo><Affiliation>Center for Health Incentives and Behavioral Economics, Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Glanz</LastName><ForeName>Karen</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Putt</LastName><ForeName>Mary</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center for Health Incentives and Behavioral Economics, Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rareshide</LastName><ForeName>Charles</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Center for Health Incentives and Behavioral Economics, Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Volpp</LastName><ForeName>Kevin G</ForeName><Initials>KG</Initials><AffiliationInfo><Affiliation>Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Health Care Transformation and Innovation, University of Pennsylvania, Philadelphia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Health Incentives and Behavioral Economics, Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Health Care Management, the Wharton School, University of Pennsylvania, Philadelphia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT04714398</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D065007">Pragmatic Clinical Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>09</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JAMA Netw Open</MedlineTA><NlmUniqueID>101729235</NlmUniqueID><ISSNLinking>2574-3805</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>doi: 10.1001/jamanetworkopen.2025.29834</RefSource></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006973" MajorTopicYN="Y">Hypertension</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018660" MajorTopicYN="Y">Blood Pressure Monitoring, Ambulatory</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D060909" MajorTopicYN="Y">Economics, Behavioral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060145" MajorTopicYN="N">Text Messaging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017216" MajorTopicYN="N">Telemedicine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018579" MajorTopicYN="Y">Patient Selection</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement><b>Conflict of Interest Disclosures:</b> Dr Mehta reported receiving personal fees from Guardant Health and the American Gastroenterological Association outside the submitted work. Dr Putt reported receiving grants from the National Institutes of Health (NIH) during the conduct of the study. Dr Volpp reported receiving grants from the NIH during the conduct of the study and being a co-owner of VAL Health, a consulting company; having stock options in Thrive Global for serving on the scientific advisory board; and receiving grants from Independence Blue Cross outside the submitted work. No other disclosures were reported.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>9</Month><Day>2</Day><Hour>22</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>9</Month><Day>2</Day><Hour>22</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>9</Month><Day>2</Day><Hour>11</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>9</Month><Day>2</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40892409</ArticleId><ArticleId IdType="pmc">PMC12406065</ArticleId><ArticleId IdType="doi">10.1001/jamanetworkopen.2025.29825</ArticleId><ArticleId IdType="pii">2838314</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Muntner P, Miles MA, Jaeger BC, et al. Blood pressure control among US adults, 2009 to 2012 through 2017 to 2020. Hypertension. 2022;79(9):1971-1980. doi: 10.1161/HYPERTENSIONAHA.122.19222</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.122.19222</ArticleId><ArticleId IdType="pmc">PMC9370255</ArticleId><ArticleId IdType="pubmed">35616029</ArticleId></ArticleIdList></Reference><Reference><Citation>Forouzanfar MH, Liu P, Roth GA, et al. Global burden of hypertension and systolic blood pressure of at least 110 to 115 mm Hg, 1990-2015. JAMA. 2017;317(2):165-182. doi: 10.1001/jama.2016.19043</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2016.19043</ArticleId><ArticleId IdType="pubmed">28097354</ArticleId></ArticleIdList></Reference><Reference><Citation>Murray CJL, Lopez AD. Measuring the global burden of disease. N Engl J Med. 2013;369(5):448-457. doi: 10.1056/NEJMra1201534</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1201534</ArticleId><ArticleId IdType="pubmed">23902484</ArticleId></ArticleIdList></Reference><Reference><Citation>Chobufo MD, Gayam V, Soluny J, et al. Prevalence and control rates of hypertension in the USA: 2017-2018. Int J Cardiol Hypertens. 2020;6:100044. doi: 10.1016/j.ijchy.2020.100044</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijchy.2020.100044</ArticleId><ArticleId IdType="pmc">PMC7803011</ArticleId><ArticleId IdType="pubmed">33447770</ArticleId></ArticleIdList></Reference><Reference><Citation>Bosworth HB, Powers BJ, Olsen MK, et al. Home blood pressure management and improved blood pressure control: results from a randomized controlled trial. Arch Intern Med. 2011;171(13):1173-1180. doi: 10.1001/archinternmed.2011.276</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinternmed.2011.276</ArticleId><ArticleId IdType="pubmed">21747013</ArticleId></ArticleIdList></Reference><Reference><Citation>Margolis KL, Asche SE, Bergdall AR, et al. Effect of home blood pressure telemonitoring and pharmacist management on blood pressure control: a cluster randomized clinical trial. JAMA. 2013;310(1):46-56. doi: 10.1001/jama.2013.6549</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2013.6549</ArticleId><ArticleId IdType="pmc">PMC4311883</ArticleId><ArticleId IdType="pubmed">23821088</ArticleId></ArticleIdList></Reference><Reference><Citation>Omboni S, Guarda A. Impact of home blood pressure telemonitoring and blood pressure control: a meta-analysis of randomized controlled studies. Am J Hypertens. 2011;24(9):989-998. doi: 10.1038/ajh.2011.100</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ajh.2011.100</ArticleId><ArticleId IdType="pubmed">21654858</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi WS, Choi JH, Oh J, Shin IS, Yang JS. Effects of remote monitoring of blood pressure in management of urban hypertensive patients: a systematic review and meta-analysis. Telemed J E Health. 2020;26(6):744-759. doi: 10.1089/tmj.2019.0028</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/tmj.2019.0028</ArticleId><ArticleId IdType="pubmed">31532328</ArticleId></ArticleIdList></Reference><Reference><Citation>Uhlig K, Patel K, Ip S, Kitsios GD, Balk EM. Self-measured blood pressure monitoring in the management of hypertension: a systematic review and meta-analysis. Ann Intern Med. 2013;159(3):185-194. doi: 10.7326/0003-4819-159-3-201308060-00008</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-159-3-201308060-00008</ArticleId><ArticleId IdType="pubmed">23922064</ArticleId></ArticleIdList></Reference><Reference><Citation>Green BB, Cook AJ, Ralston JD, et al. Effectiveness of home blood pressure monitoring, Web communication, and pharmacist care on hypertension control: a randomized controlled trial. JAMA. 2008;299(24):2857-2867. doi: 10.1001/jama.299.24.2857</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.299.24.2857</ArticleId><ArticleId IdType="pmc">PMC2715866</ArticleId><ArticleId IdType="pubmed">18577730</ArticleId></ArticleIdList></Reference><Reference><Citation>Margolis KL, Asche SE, Dehmer SP, et al. Long-term outcomes of the effects of home blood pressure telemonitoring and pharmacist management on blood pressure among adults with uncontrolled hypertension: follow-up of a cluster randomized clinical trial. JAMA Netw Open. 2018;1(5):e181617. doi: 10.1001/jamanetworkopen.2018.1617</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2018.1617</ArticleId><ArticleId IdType="pmc">PMC6324502</ArticleId><ArticleId IdType="pubmed">30646139</ArticleId></ArticleIdList></Reference><Reference><Citation>Cappuccio FP, Kerry SM, Forbes L, Donald A. Blood pressure control by home monitoring: meta-analysis of randomised trials. BMJ. 2004;329(7458):145. doi: 10.1136/bmj.38121.684410.AE</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.38121.684410.AE</ArticleId><ArticleId IdType="pmc">PMC478224</ArticleId><ArticleId IdType="pubmed">15194600</ArticleId></ArticleIdList></Reference><Reference><Citation>Kronish IM, Kent S, Moise N, et al. Barriers to conducting ambulatory and home blood pressure monitoring during hypertension screening in the United States. J Am Soc Hypertens. 2017;11(9):573-580. doi: 10.1016/j.jash.2017.06.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jash.2017.06.012</ArticleId><ArticleId IdType="pmc">PMC5595651</ArticleId><ArticleId IdType="pubmed">28734798</ArticleId></ArticleIdList></Reference><Reference><Citation>Kahneman D, Tversky A. Prospect theory: an analysis of decision under risk. Econometrica. 1979;47(2):263-291. doi: 10.2307/1914185</Citation><ArticleIdList><ArticleId IdType="doi">10.2307/1914185</ArticleId></ArticleIdList></Reference><Reference><Citation>Tversky A, Kahneman D. Judgment under uncertainty: heuristics and biases. Science. 1974;185(4157):1124-1131. doi: 10.1126/science.185.4157.1124</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.185.4157.1124</ArticleId><ArticleId IdType="pubmed">17835457</ArticleId></ArticleIdList></Reference><Reference><Citation>Tversky A, Kahneman D. The framing of decisions and the psychology of choice. Science. 1981;211(4481):453-458. doi: 10.1126/science.7455683</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.7455683</ArticleId><ArticleId IdType="pubmed">7455683</ArticleId></ArticleIdList></Reference><Reference><Citation>Chapman GB, Li M, Colby H, Yoon H. Opting in vs opting out of influenza vaccination. JAMA. 2010;304(1):43-44. doi: 10.1001/jama.2010.892</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2010.892</ArticleId><ArticleId IdType="pubmed">20606147</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta SJ, Khan T, Guerra C, et al. A randomized controlled trial of opt-in versus opt-out colorectal cancer screening outreach. Am J Gastroenterol. 2018;113(12):1848-1854. doi: 10.1038/s41395-018-0151-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41395-018-0151-3</ArticleId><ArticleId IdType="pmc">PMC6768589</ArticleId><ArticleId IdType="pubmed">29925915</ArticleId></ArticleIdList></Reference><Reference><Citation>Waddell KJ, Mehta SJ. Designing effective and appropriate opt-out approaches for patient outreach. JAMA Intern Med. 2023;183(11):1194-1195. doi: 10.1001/jamainternmed.2023.4628</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2023.4628</ArticleId><ArticleId IdType="pmc">PMC10810178</ArticleId><ArticleId IdType="pubmed">37695578</ArticleId></ArticleIdList></Reference><Reference><Citation>Kahneman D, Knetsch JL, Thaler RH. Anomalies: the endowment effect, loss aversion, and status quo bias. J Econ Perspect. 1991;5(1):193-206. doi: 10.1257/jep.5.1.193</Citation><ArticleIdList><ArticleId IdType="doi">10.1257/jep.5.1.193</ArticleId></ArticleIdList></Reference><Reference><Citation>Cialdini RB, Trost MR. Social influence: social norms, conformity and compliance. In: Gilbert DT, Fiske ST, Lindzey G, eds. The Handbook of Social Psychology. 4th ed. McGraw-Hill; 1998:151-192.</Citation></Reference><Reference><Citation>Asch DA, Rosin R. Engineering social incentives for health. N Engl J Med. 2016;375(26):2511-2513. doi: 10.1056/NEJMp1603978</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMp1603978</ArticleId><ArticleId IdType="pubmed">28029924</ArticleId></ArticleIdList></Reference><Reference><Citation>Asch DA, Ziolek TA, Mehta SJ. Misdirections in informed consent&#x2014;impediments to health care innovation. N Engl J Med. 2017;377(15):1412-1414. doi: 10.1056/NEJMp1707991</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMp1707991</ArticleId><ArticleId IdType="pubmed">29020586</ArticleId></ArticleIdList></Reference><Reference><Citation>James PA, Oparil S, Carter BL, et al. 2014 Evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311(5):507-520. doi: 10.1001/jama.2013.284427</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2013.284427</ArticleId><ArticleId IdType="pubmed">24352797</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharman JE, Blizzard L, Kosmala W, Nelson MR. Pragmatic method using blood pressure diaries to assess blood pressure control. Ann Fam Med. 2016;14(1):63-69. doi: 10.1370/afm.1883</Citation><ArticleIdList><ArticleId IdType="doi">10.1370/afm.1883</ArticleId><ArticleId IdType="pmc">PMC4709157</ArticleId><ArticleId IdType="pubmed">26755785</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta SJ, Volpp KG, Troxel AB, et al. Remote blood pressure monitoring with social support for patients with hypertension: a randomized clinical trial. JAMA Netw Open. 2024;7(6):e2413515. doi: 10.1001/jamanetworkopen.2024.13515</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2024.13515</ArticleId><ArticleId IdType="pmc">PMC11148689</ArticleId><ArticleId IdType="pubmed">38829618</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta SJ, Day SC, Norris AH, et al. Behavioral interventions to improve population health outreach for hepatitis C screening: randomized clinical trial. BMJ. 2021;373(1022):n1022. doi: 10.1136/bmj.n1022</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1022</ArticleId><ArticleId IdType="pmc">PMC8129827</ArticleId><ArticleId IdType="pubmed">34006604</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta SJ, Rhodes C, Linn KA, et al. Behavioral interventions to improve breast cancer screening outreach: two randomized clinical trials. JAMA Intern Med. 2024;184(7):761-768. doi: 10.1001/jamainternmed.2024.0495</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2024.0495</ArticleId><ArticleId IdType="pmc">PMC11074930</ArticleId><ArticleId IdType="pubmed">38709509</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta SJ, Troxel AB, Marcus N, et al. Participation rates with opt-out enrollment in a remote monitoring intervention for patients with myocardial infarction. JAMA Cardiol. 2016;1(7):847-848. doi: 10.1001/jamacardio.2016.2374</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2016.2374</ArticleId><ArticleId IdType="pmc">PMC6140334</ArticleId><ArticleId IdType="pubmed">27603755</ArticleId></ArticleIdList></Reference><Reference><Citation>Kahneman D, Knetsch JL, Thaler RH. Experimental tests of the endowment effect and the Coase theorem. J Polit Econ. 1990;98(6):1325-1348. doi: 10.1086/261737</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/261737</ArticleId></ArticleIdList></Reference><Reference><Citation>Noah B, Keller MS, Mosadeghi S, et al. Impact of remote patient monitoring on clinical outcomes: an updated meta-analysis of randomized controlled trials. NPJ Digit Med. 2018;1(1):20172. doi: 10.1038/s41746-017-0002-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41746-017-0002-4</ArticleId><ArticleId IdType="pmc">PMC6550143</ArticleId><ArticleId IdType="pubmed">31304346</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta SJ, Volpp KG, Troxel AB, et al. Electronic pill bottles or bidirectional text messaging to improve hypertension medication adherence (Way 2 Text): a randomized clinical trial. J Gen Intern Med. 2019;34(11):2397-2404. doi: 10.1007/s11606-019-05241-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11606-019-05241-x</ArticleId><ArticleId IdType="pmc">PMC6848522</ArticleId><ArticleId IdType="pubmed">31396815</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>